Medication info
Rocatan Tablets 25 mg (Losartan Potassium)

Rocatan Tablets 25 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202503377 · Approved 2025.12.24

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. 2) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25mg once daily is recommended. 4) Patients with reduced intravascular volume For a small number of patients who may have reduced intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25mg of this medicine once daily is recommended. (See the section 'Precautions for use'.) 5) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. 7) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50mg of this medicine once daily. The dose may be increased to 100mg once daily depending on blood pressure. However, an initial dose of 25mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).
Child dose
Children and adolescents aged 6 years and older who weigh 20kg or more and less than 50kg and are able to swallow tablets: The recommended dose is 25mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50mg of this medicine once daily, which may be increased to a maximum of 100mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension

  • Hypertension
  • nephropathy in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension. It particularly helps in preventing or delaying the progression of nephropathy in patients with type 2 diabetes who have hypertension. Therefore, it is effective in reducing the risk of cardiovascular diseases associated with hypertension and protecting kidney health.

How to take

Adult dose

1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. 2) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25mg once daily is recommended. 4) Patients with reduced intravascular volume For a small number of patients who may have reduced intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25mg of this medicine once daily is recommended. (See the section 'Precautions for use'.) 5) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. 7) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50mg of this medicine once daily. The dose may be increased to 100mg once daily depending on blood pressure. However, an initial dose of 25mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).

Child dose

Children and adolescents aged 6 years and older who weigh 20kg or more and less than 50kg and are able to swallow tablets: The recommended dose is 25mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50mg of this medicine once daily, which may be increased to a maximum of 100mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. Patients with a known allergy to this drug, severe liver impairment, or certain genetic disorders should not use it. Elderly patients, those with impaired renal function, or patients with hyperkalemia should use this medication cautiously as there is a risk of rapid blood pressure drop, requiring careful monitoring. Dizziness or drowsiness may occur while taking this medication, so caution is necessary when driving or operating machinery. While this medication is effective in lowering blood pressure, rare side effects such as liver dysfunction, worsening kidney function, blood disorders, and muscle pain may occur. Any unusual symptoms should prompt immediate consultation with a healthcare professional. Interactions may occur when taken with other medications, particularly potassium supplements, potassium-sparing diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), and lithium. Patients should inform their doctor if they are taking these medications. Taking this drug during pregnancy can lead to decreased renal function in the fetus, pulmonary developmental issues, skeletal malformations, etc., so it should be discontinued immediately upon confirmation of pregnancy. During breastfeeding, there is a possibility that this drug may be excreted into breast milk, so it is advisable to discontinue nursing or avoid taking this medication. This drug is not indicated for children under 6 years of age or for children and adolescents with severely impaired renal function. In the case of overdose, hypotension and bradycardia may occur, requiring immediate medical attention. It is important to regularly monitor blood pressure, kidney function, and electrolyte levels while taking this medication for any abnormalities.

Side effects

  • Muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
Show 122 more
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm peeling
  • hemolytic phenomenon
  • facial swelling
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • dental pain
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • myopathy
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • nervous irritability
  • paresthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnolence
  • tremor
  • dizziness
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • thoracic discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning eyes
  • eye pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • malaise
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • dry cough
  • erythroderma
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • renal failure
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius at room temperature. This will help preserve the drug's efficacy safely for a long time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.